ER004

· EspeRare Foundation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ER004, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia [Phase 2]